Kasper D L, Onderdonk A B, Bartlett J G
J Infect Dis. 1977 Dec;136(6):789-95. doi: 10.1093/infdis/136.6.789.
The humoral antibody response to the capsular polysaccharide of Bacteroides fragilis was quantitated in an animal model of intraabdominal abscess formation using a sensitive quantitative radioactive antigen-binding assay. Antibody detected by this technique correlated highly with antibody measured by quantitative precipitin analysis (r = 0.943). Animals infected with encapsulated B. fragilis develop high levels of circulating serum antibody to the capsular polysaccharide. This antibody can be induced by implantation of live organisms, heat-killed organisms, heterologous strains of B. fragilis, and various outer membrane components that contain the capsular antigen. The immunogenicity of the capsular polysaccharide could be enhanced when administered as part of the outer membrane or when not separated from outer membrane proteins. Evidence of an antibody response to this capsular polysaccharide offers support for the demonstrated pathogenic potential of encapsulated B. fragilis.
在腹腔脓肿形成的动物模型中,采用灵敏的定量放射性抗原结合试验,对脆弱拟杆菌荚膜多糖的体液抗体反应进行了定量分析。用该技术检测到的抗体与通过定量沉淀分析测定的抗体高度相关(r = 0.943)。感染了有荚膜脆弱拟杆菌的动物会产生高水平的针对荚膜多糖的循环血清抗体。这种抗体可由活生物体、热灭活生物体、脆弱拟杆菌的异源菌株以及各种含有荚膜抗原的外膜成分诱导产生。当作为外膜的一部分给药或不与外膜蛋白分离时,荚膜多糖的免疫原性会增强。对这种荚膜多糖产生抗体反应的证据,为已证实的有荚膜脆弱拟杆菌的致病潜力提供了支持。